Dr. Bill Wilson calls GLP-1 drugs a "master switch" that directly addresses insulin resistance and metabolic disease. He says they substantially improve outcomes in cardiovascular, renal, and liver disease, though they're not cures.
Chapters
They're right at the floodgate of chronic diseases in our modern society. Almost all of those diseases are tied into insulin resistance and metabolic problems. These drugs directly impact that in a positive way that. That we don't. We, you know, in the past, we've had metformin and bunch of other things that, you know, that that's the best we had. But they, they're Nothing like the GLPs. This is like the master switch they found. And, you know, they're truly miracle drugs because we've gotten to the core of what's driving most of our chronic diseases. In my opinion, that's cardiovascular disease, renal disease, liver disease. All of those problems are positively. They're not cured necessarily, but they have a very positive impact with these drugs.